NINDS Neuroscience Funding Announcements

Skip secondary menu

New Information from NINDS Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transtion by registering with Grants.gov and NIH eRA Commons now.



Pathogenesis and Treatment of Dyskinesias in Parkinson's Disease
Release Date: July 18, 2002
Announcement Number: PAS-02-129
Application Receipt Date:
October 1, 2002
February 1, 2003
June 1, 2003
October 1, 2003
February 1, 2004
June 1, 2004
October 1, 2004
February 1, 2005
June 1, 2005
   

Funding Contact: NINDS Funding
Program Area: Neurodegeneration

Brief Description:
With this Program Announcement, the National Institute of Neurological Disorders and Stroke (NINDS) invites research grant applications (R01) that address the development and treatment of dopamine-induced dyskinesias, a major complication of current pharmacotherapy of Parkinson's disease. The purpose of this initiative is to 1) support the study of the pathophysiologic basis of dopamine-induced dyskinesias; and 2) support the study of non- dopaminergic pharmacologic agents for the treatment of dopamine-induced dyskinesias.

Choose an option to view additional funding announcements
New Announcements | Research Area | RFAs Only | PAs Only | RFPs Only | Notices Only | Supplements Only | All Announcements | Archives